I am a Doctor
I am a Patient

Understanding Fatty Liver

What is

Fatty Liver Diseases

Fatty liver disease is one of the most common liver conditions worldwide. It occurs when excess fat builds up in the liver and is closely linked with metabolic health problems such as obesity, type 2 diabetes, high blood pressure, and abnormal cholesterol levels. In medical terms, fatty liver disease is now called:
MASLD (Metabolic dysfunction–associated steatotic liver disease)
MASH (Metabolic dysfunction–associated steatohepatitis)

What are MASLD and MASH?

MASLD (Metabolic dysfunction–associated fatty liver disease)

MASLD is a condition where excess fat builds up in the liver in the presence of metabolic risk factors. These may include overweight or obesity, type 2 diabetes, high blood pressure, or abnormal cholesterol levels.

Earlier, this condition was known as non-alcoholic fatty liver disease (NAFLD), but the updated term emphasizes its strong link with metabolic health problems.

MASH (Metabolic dysfunction–associated steatohepatitis)

MASH represents a more advanced and active stage of fatty liver disease. In this stage, fat accumulation in the liver is associated with:
  • 1. Liver inflammation
  • 2. Liver cell damage
  • 3. Formation of scar tissue (fibrosis)

This stage is linked with a higher risk of serious outcomes such as cirrhosis, liver failure, and liver cancer.

Progression of Fatty Liver Disease

The progression of fatty liver disease involves several interconnected processes:
  • 1

Insulin resistance

Excess calorie intake and metabolic imbalance reduce insulin sensitivity, leading to increased fat storage in the liver.
  • 2

Lipotoxicity

Certain forms of fat can directly damage liver cells, contributing to worsening injury.
  • 3

Oxidative stress & inflammation

Damaged liver cells trigger inflammatory responses that further accelerate liver damage.
  • 4

Fibrosis (scarring)

With ongoing inflammation, scar tissue gradually forms in the liver. Over time, this can impair normal liver function.
  • People with MASH tend to experience faster progression of liver damage compared to simple fatty liver.
  • MASLD and MASH are measured by fibrosis staging. Fibrosis stage is the strongest predictor of long-term liver outcomes.

Who Is at Risk for MASLD and MASH?

People with overweight or obesity are more likely to get MASLD and MASH. The risk is even higher in people with type 2 diabetes. Other risk factors include:

Being 40 or older

Smoking

High blood pressure

High cholesterol

Not moving around much

A diet high in sugar and saturated fat

What are sign and symptoms of MASLD and MASH?

Many people with MASLD or MASH don’t feel sick at first.
Possible early symptoms include:

Fatigue

Weakness

Feeling bloated or unwell

Pain on the right side of the belly

Health Impact of MASLD and MASH

MASLD and MASH are not limited to liver health alone. They reflect underlying metabolic imbalance in the body and are strongly linked with increased risk of long-term chronic diseases.

Increased risk of heart disease

The most common cause of death in people with MASLD and MASH is not liver failure but cardiovascular disease, including heart attacks and strokes.

Fat accumulation in the liver is closely associated with insulin resistance, abnormal cholesterol levels, inflammation, and high blood pressure all of which contribute to heart disease risk.

Link with type 2 diabetes

MASLD and type 2 diabetes are strongly interconnected. Each condition can worsen the other, and people with diabetes are at significantly higher risk of developing advanced fatty liver disease and faster progression.

Risk of advanced liver disease

As MASLD progresses to MASH, ongoing inflammation can lead to:

  • Liver scarring (fibrosis)
  • Cirrhosis
  • Liver failure
  • Liver cancer

Among these, the degree of fibrosis is the most important factor in predicting long-term outcomes.

Effect on daily life

Even in earlier stages, fatty liver disease may affect quality of life, causing:

  • Persistent fatigue
    Low energy levels
  • Reduced physical activity

In more advanced stages, symptoms may progress to fluid retention, muscle loss, and difficulty with daily functioning.

Key Message:

Fatty liver disease (MASLD and MASH) is closely linked with metabolic health conditions such as obesity, type 2 diabetes, and cardiovascular disease. It often develops silently, but early lifestyle changes reduce progression and long-term complications.

I confirm that I am a patient who has been prescribed with medication.

Proceed
I am a Doctor
I am a Patient